Our mission

To prevent vision loss and address unmet medical needs in ophthalmology.


Our focus

Advanced research to deliver best-in-class therapies for back of the eye diseases.



Oxurion NV Reports Additional Positive Topline Phase 1 Results with THR-149

Read more


Perspectives Magazine

Discover inspiring interviews, last year's milestones and our future plans

Download here


Eye care

Diabetics risk serious eye disease. Together with Prevent Blindness, Oxurion urges diabetics to get an eye check regularly.

Read more


Finance Avenue

Tour & Taxis, Brussels, 16 November 2019

Meet the team at the Oxurion booth (#108) or join our presentation at 14.05 in Finance Corner 4

Read more

Delivering next-generation treatments for back of the eye disorders, with focus on diabetic eye disease

Advancing Science. Enhancing Vision.

Oxurion builds on a yearlong expertise and knowledge platform resulting from local and international scientific collaboration. In today’s rebranding, we further embrace our core expertise and evoke our aspirations for the future. As before, we are driven by the ambition to expand our activities, building on our past, into new areas.

We are advancing our pipeline of disease-modifying drug candidates to preserve vision for patients with back of the eye disorders and look forward to sharing the progress of our clinical programs.

- Patrik De Haes, MD, CEO of Oxurion


We embrace all efforts to tackle diabetes and related vision loss

Read full story

Join forces to fight eye disease in developing countries

Read full story

Raising awareness for diabetic eye disease

Read full story


Oxurion employs 75 people worldwide, all are united by a shared goal: to make Oxurion a global leader in developing and commercializing innovative treatments for chronic eye disorders. Want to join us?

Visit our careers site


Oxurion relies on a network of experienced partners to bring the best possible eye care to patients across the globe. We are always open to new opportunities for partnership and collaboration for improving eye care.

Want to become a partner? Contact us!

Stay in touch

Be sure to check in regularly for the latest news about our our company, research & development activities and updates for investors or just subscribe to our mailing list to receive regular updates.

Read our latest news or Subscribe